Safety and Efficacy Study of TLL018 in the Treatment of Ulcerative Colitis

A Study to Assess the Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of rhuMAb Beta7 in Patients With Ulcerative Colitis

NCT00694980 ·Status: COMPLETED ·Phase: PHASE1

Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181.

NCT01290042 ·Status: COMPLETED ·Phase: PHASE1

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181 in Healthy Subjects and Subjects With Mild to Moderate Ulcerative Colitis

NCT01164904 ·Status: TERMINATED ·Phase: PHASE1

A Trial of Rosiglitazone for Ulcerative Colitis

NCT00065065 ·Status: COMPLETED ·Phase: PHASE2

A Study To Evaluate The Safety And Efficacy Of PF-06826647 In Participants With Moderate To Severe Ulcerative Colitis

NCT04209556 ·Status: WITHDRAWN ·Phase: PHASE2

A Study of Tofacitinib in Patients With Ulcerative Colitis in Stable Remission

NCT03281304 ·Status: TERMINATED ·Phase: PHASE4

A Multicenter, Randomized, Double-Blind, Placebo Controlled Induction Study to Evaluate the Efficacy and Safety of Risankizumab in Participants With Moderately to Severely Active Ulcerative Colitis

NCT03398148 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Efficacy and Safety of LC51-0255 in Subjects With Ulcerative Colitis

NCT04096573 ·Status: WITHDRAWN ·Phase: PHASE2

A Study Evaluating the Efficacy and Safety of ST-0529 in Subjects With Moderately to Severely Active Ulcerative Colitis

NCT03844932 ·Status: TERMINATED ·Phase: PHASE2

A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis

NCT01458951 ·Status: COMPLETED ·Phase: PHASE3

Efficacy & Safety of TD-1473 in Ulcerative Colitis

NCT03758443 ·Status: TERMINATED ·Phase: PHASE2/PHASE3

A Study Comparing the Efficacy and Safety of Etrolizumab With Adalimumab and Placebo in Participants With Moderate to Severe Ulcerative Colitis (UC) in Participants Naive to Tumor Necrosis Factor (TNF) Inhibitors

NCT02171429 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Safety and Efficacy of Itacitinib in Moderate to Severe Ulcerative Colitis

NCT03627052 ·Status: WITHDRAWN ·Phase: PHASE2

Efficacy and Safety of GLPG1205 in Subjects With Active Ulcerative Colitis

NCT02337608 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)

NCT06979336 ·Status: RECRUITING ·Phase: PHASE2

A Study to Learn About the Safety, Effects and Pharmacokinetics of Study Medication (PF-07054894) for the Treatment of Ulcerative Colitis

NCT05549323 ·Status: TERMINATED ·Phase: PHASE1

Study to Evaluate the Safety and Efficacy of Two Adalimumab Dosing Regimens in Subjects With Moderate to Severe Ulcerative Colitis

NCT02065622 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of Adalimumab in Subjects With Moderately to Severely Active Ulcerative Colitis

NCT00408629 ·Status: COMPLETED ·Phase: PHASE3

Nicotinamide Riboside in Ulcerative Colitis

NCT05561738 ·Status: RECRUITING ·Phase: NA

Open-Label Adalimumab for Ulcerative Colitis Patients

NCT00421642 ·Status: COMPLETED ·Phase: PHASE1

Safety, Efficacy, and Tolerability Study of PF-06480605 in Subjects With Moderate to Severe Ulcerative Colitis.

NCT02840721 ·Status: COMPLETED ·Phase: PHASE2

Evaluation of SPH3127 in Patients With Mild-to-Moderate Ulcerative Colitis

NCT05019742 ·Status: TERMINATED ·Phase: PHASE2

Efficacy and Safety of Adalimumab in Pediatric Subjects With Moderate to Severe Ulcerative Colitis

NCT02065557 ·Status: COMPLETED ·Phase: PHASE3

Generate Real World Data On Tofacitinib Induction Therapy and Changes In Clinical and Patient Reported Outcomes.

NCT05069259 ·Status: TERMINATED

Safety, Efficacy, Pharmacokinetic and Pharmacodynamic Study of GLPG0974 in Subjects With Ulcerative Colitis

NCT01829321 ·Status: COMPLETED ·Phase: PHASE2